Subacute cutaneous lupus erythematosus (SCLE) is an autoimmune condition that primarily affects the skin, causing distinctive rashes and lesions that appear mainly on sun-exposed areas of the body. Unlike some other forms of lupus, this condition usually doesn’t leave permanent scars, though it can cause temporary skin discoloration and may require careful long-term management to keep symptoms under control.

What Is Subacute Cutaneous Lupus Erythematosus?

Subacute cutaneous lupus erythematosus is one specific form of cutaneous lupus erythematosus, which is a type of lupus that affects the skin. In this condition, your immune system mistakenly attacks healthy skin tissue, leading to inflammation and visible rashes. The term “subacute” refers to the depth of inflammation that doctors can see when they examine a small sample of skin under a microscope^[1].

People with SCLE develop red, ring-shaped or raised patches on parts of their body that are typically exposed to sunlight, such as the neck, shoulders, upper chest, back, and arms. The face is usually spared from these rashes. What makes SCLE different from other types of skin lupus is that these lesions generally heal without leaving permanent scars, though they may cause areas of lighter or darker skin that can take time to fade^[1].

About half of people with subacute cutaneous lupus also have systemic lupus erythematosus (SLE), which is the more common form of lupus that can affect multiple organs throughout the body. However, when SCLE occurs alongside systemic lupus, the severity of symptoms affecting internal organs tends to be milder, and serious complications involving the kidneys or nervous system happen less frequently^[3].

Types of Subacute Cutaneous Lupus

SCLE can appear in two main forms, and some people may experience both types at the same time. The first type is called annular SCLE, which causes red, raised, ring-shaped patches that can spread across sun-exposed areas. These circular lesions may connect to form overlapping patterns that look like interlocking circles. When these annular lesions heal, they often leave behind areas of lightened skin known as hypopigmentation^[1].

The second type is papulosquamous SCLE, which creates a rash that combines small raised bumps with scaly patches. This form may look similar to psoriasis or eczema, which can sometimes make diagnosis more challenging. Like the annular type, papulosquamous SCLE is triggered by sunlight and appears primarily on sun-exposed areas of the body^[1].

How Common Is Subacute Cutaneous Lupus Erythematosus?

SCLE affects approximately 10% of all people diagnosed with lupus, making it less common than some other forms of the disease. While anyone can develop SCLE regardless of age, sex, or ethnicity, certain groups face a higher risk^[4].

The condition is most frequently diagnosed in middle-aged women, particularly those between the ages of 40 and 60. In North America, SCLE appears to be more common in people of white or Caucasian descent compared to other ethnic groups. Women are affected more often than men, though the gender difference is not as dramatic as it is with systemic lupus erythematosus^[1][3].

What Causes Subacute Cutaneous Lupus Erythematosus?

The exact cause of SCLE remains complex and not fully understood. Researchers believe the condition develops through a combination of genetic susceptibility and environmental triggers. The immune system loses its normal ability to distinguish between harmful invaders and the body’s own healthy tissue, leading it to attack skin cells inappropriately^[2].

Ultraviolet radiation from sunlight is the classic trigger for SCLE. When skin is exposed to UV light, it appears to increase the expression of certain proteins called Ro/SSA antigens on the surface of skin cells. In people with SCLE, antibodies in the blood bind to these antigens, causing an inflammatory reaction that produces the characteristic rashes^[4].

Medications are another significant cause of SCLE. In about one-third of people with the condition, symptoms develop after taking certain prescription drugs. The time it takes for drug-induced SCLE to appear varies widely—from just a few days with some chemotherapy medications to several years after starting drugs like thiazide diuretics^[4].

The medications most commonly associated with SCLE include thiazide diuretics (water pills used for high blood pressure), terbinafine (an antifungal medication), and calcium channel blockers (heart medications). Other drugs that may trigger SCLE include proton pump inhibitors used for acid reflux, ACE inhibitors for blood pressure, tumor necrosis factor inhibitors for autoimmune conditions, and certain chemotherapy agents^[1][4].

Beyond medications and UV exposure, other environmental factors may contribute to developing SCLE. Tobacco use, exposure to certain pesticides, and stress levels have all been identified as potential contributing factors^[1].

Who Is at Risk for Developing SCLE?

Genetic factors play an important role in determining who develops subacute cutaneous lupus erythematosus. The condition has a strong association with specific genes that control immune system function. People who carry certain human leukocyte antigen (HLA) markers—particularly HLA-B8, HLA-DR3, HLA-DRw52, and HLA-DQ1—have an increased risk of developing SCLE^[3].

Having a family history of lupus significantly increases your risk, as the condition runs in families. If you have a biological parent with lupus, your chances of developing some form of lupus, including SCLE, are higher than average^[1].

Beyond genetics, certain demographic factors influence risk. Women face a higher risk than men, and people between the ages of 40 and 60 are most commonly diagnosed. White individuals appear to have a higher incidence of SCLE compared to other racial and ethnic groups in North America^[1][3].

SCLE can also be associated with other autoimmune conditions. Some people with SCLE also have Sjögren syndrome, rheumatoid arthritis, or Crohn disease. Additionally, there are increasing reports of SCLE appearing in people with certain types of cancer, including lung, esophageal, and prostate cancers, as well as cholangiocarcinoma and B-cell lymphoma^[4].

Symptoms and How They Affect Daily Life

The primary symptom of subacute cutaneous lupus erythematosus is a distinctive rash that appears on sun-exposed parts of the body. The rash typically develops on the neck, upper chest, upper back, shoulders, and the outer surfaces of the arms. Unlike some other forms of lupus, the face is often spared, which helps doctors distinguish SCLE from acute cutaneous lupus^[2].

The appearance of the rash can vary depending on which type of SCLE you have. Some people see red, ring-shaped raised patches with clear centers that may join together to form connected circular patterns. Others develop red, bumpy, scaly skin that resembles psoriasis. In some cases, there may be small blisters, crusting, or areas where blood vessels are visible near the surface of the skin^[1][4].

What makes SCLE somewhat unique among skin conditions is that the rashes typically don’t itch or cause significant pain. However, when the lesions eventually clear up, they often leave behind patches of skin discoloration. These areas may be lighter than the surrounding skin, a condition called hypopigmentation. While this discoloration is not permanent, it can take a considerable amount of time for skin tone to return to normal^[1][4].

Beyond the skin rashes, people with SCLE may experience other symptoms related to lupus. About half of those with SCLE have diffuse hair loss that doesn’t cause permanent bald patches. Mouth ulcers can develop, causing discomfort when eating or drinking. Some people notice a lacy, purplish discoloration on their skin called livedo reticularis, or small dilated blood vessels around the fingernails called periungual telangiectasia^[4].

Around 50% of people with SCLE meet the medical criteria for systemic lupus erythematosus, meaning they have symptoms beyond the skin. These may include joint pain, muscle aches, fatigue, and mild illness. However, severe complications affecting the kidneys or central nervous system are less common in SCLE compared to other forms of lupus^[4].

How Doctors Diagnose SCLE

Diagnosing subacute cutaneous lupus erythematosus requires a combination of clinical evaluation, laboratory tests, and sometimes microscopic examination of skin tissue. A dermatologist (a doctor who specializes in skin conditions) or a rheumatologist (a doctor who specializes in autoimmune diseases and arthritis) typically makes the diagnosis^[1].

Your doctor will begin by performing a physical examination and asking detailed questions about your symptoms. They’ll want to know when the rash first appeared, whether it gets worse after sun exposure, what medications you’re taking, and whether you have any other symptoms like joint pain or fatigue. The appearance and distribution of your rash provide important clues that help distinguish SCLE from other skin conditions^[2].

A skin biopsy is often necessary to confirm the diagnosis. During this procedure, your doctor removes a small sample of skin from an affected area. The sample is sent to a laboratory where it’s examined under a microscope. The microscopic changes in SCLE have a characteristic pattern that helps pathologists identify the condition. If the diagnosis remains uncertain after standard examination, a special test called direct immunofluorescence may be performed. This test reveals a distinctive pattern of immune proteins deposited at the junction between the outer and inner layers of skin^[1][5].

Blood tests play an important role in diagnosis and help determine whether you have systemic involvement. More than 70% of people with SCLE test positive for antibodies called anti-Ro (SS-A), and many also have anti-La (SS-B) antibodies. These are known as extractable nuclear antigens, and their presence supports the diagnosis of SCLE. Other blood tests may check for signs of inflammation, anemia, or other autoimmune markers^[3][6].

If you’re diagnosed with SCLE, your doctor will also assess whether you have systemic lupus erythematosus. This may involve additional blood tests, urine tests to check kidney function, and a thorough medical evaluation to look for signs of organ involvement. Many people with SCLE fulfill four or more of the diagnostic criteria for SLE, though their systemic disease tends to be milder^[3].

Prevention Strategies and Lifestyle Changes

While there’s no way to completely prevent subacute cutaneous lupus erythematosus from developing if you’re genetically predisposed, there are important steps you can take to prevent flare-ups and minimize symptoms. The most critical preventive measure is protecting your skin from ultraviolet radiation^[12].

Sun protection should become a daily habit, regardless of weather or season. Apply a broad-spectrum sunscreen with a sun protection factor (SPF) of 50 or higher every morning, at least 20 minutes before going outside. Sunscreen should be reapplied every two to three hours throughout the day, especially if you’re sweating or have been in water. Look for sunscreens that protect against both UVA and UVB radiation, sometimes labeled as “broad-spectrum”^[12].

Beyond sunscreen, physical barriers provide excellent protection. Wear protective clothing when outdoors, including long-sleeved shirts, long pants, and wide-brimmed hats that shade your face, neck, and ears. Some clothing manufacturers now produce garments with built-in UV protection. Seek shade whenever possible, especially during peak sun hours between 10 a.m. and 4 p.m.^[12].

Avoiding or quitting smoking is another important preventive step. Tobacco use has been identified as a potential trigger for SCLE, and smoking may worsen symptoms in people who already have the condition^[1].

If your SCLE is drug-induced, stopping the medication that triggered it is essential. However, you should never discontinue a prescribed medication without first discussing it with your doctor, as abruptly stopping some medications can cause serious health problems^[6].

Understanding How SCLE Affects Your Body

At a cellular level, subacute cutaneous lupus erythematosus represents a breakdown in immune tolerance. Your immune system, which normally protects you from infections and diseases, begins producing antibodies that target your body’s own tissues. In SCLE, these autoantibodies particularly target proteins found in skin cells^[2].

When ultraviolet light strikes your skin, it triggers a cascade of events in people with SCLE. The UV radiation causes certain proteins inside skin cells, particularly the Ro/SSA antigen, to move to the cell surface where they become visible to the immune system. In people with SCLE who have anti-Ro antibodies circulating in their blood, these antibodies bind to the Ro proteins on skin cells, marking them for attack^[4].

This binding triggers an inflammatory response. Immune cells rush to the area and release chemicals that cause redness, swelling, and tissue damage. The skin cells undergo a process called apoptosis, or programmed cell death. As these damaged and dying cells accumulate, they form the visible rashes and lesions characteristic of SCLE^[3].

Research has shown that people with SCLE have elevated levels of type I interferon-regulated genes in their blood. Interferons are signaling proteins that play a role in immune responses. This overproduction of type I interferon contributes to the inflammatory process and appears to correlate with how active and severe the skin disease is^[3].

What makes SCLE lesions different from other types of cutaneous lupus is the depth of inflammation. In SCLE, the inflammatory process affects the upper and middle layers of the skin but doesn’t extend as deeply into tissue as it does in chronic forms like discoid lupus. This is why SCLE lesions heal without permanent scarring or tissue destruction, though temporary discoloration can occur^[1].

The immune system dysregulation in SCLE isn’t limited to just attacking skin. In people who have both SCLE and systemic lupus, the same autoimmune process can affect other organs. However, the severity tends to be milder, and life-threatening complications involving the kidneys or brain occur less frequently than in typical SLE^[4].

There may also be a connection between SCLE and complement proteins, which are part of your immune system’s defense mechanism. Some people with SCLE have deficiencies in complement components C2 and C4. These deficiencies may contribute to inadequate clearing of damaged cells and cellular debris, which could perpetuate the autoimmune response^[4].